GE HealthCare Technologies Inc. (GEHC) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GEHC Revenue Growth
Revenue Breakdown (FY 2025)
GEHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
GEHC Revenue Analysis (2020–2025)
As of May 8, 2026, GE HealthCare Technologies Inc. (GEHC) generated trailing twelve-month (TTM) revenue of $19.95 billion, reflecting solid growth of +7.4% year-over-year. The most recent quarter (Q1 2026) recorded $5.13 billion in revenue, up 9.8% sequentially.
Looking at the longer-term picture, GEHC's 5-year compound annual growth rate (CAGR) stands at +3.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $20.63 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows GEHC's business is primarily driven by Imaging Segment (61%), PCS Segment (20%), and PDx Segment (19%). With over half of revenue concentrated in Imaging Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including SYK (+11.2% YoY), BSX (+19.9% YoY), and EW (+11.2% YoY), GEHC has underperformed the peer group in terms of revenue growth. Compare GEHC vs SYK →
GEHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GEHCCurrent | $20.0B | +7.4% | +3.7% | 13.4% | |
 SYK | $25.1B | +11.2% | +11.8% | 19.5% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 EW | $6.1B | +11.2% | +6.7% | 27.0% | |
 PHG | $17.8B | -1.0% | +0.6% | 8.0% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
GEHC Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $20.63B | +4.8% | $8.25B | 40.0% | $2.76B | 13.4% |
| 2024 | $19.67B | +0.6% | $8.21B | 41.7% | $2.63B | 13.3% |
| 2023 | $19.55B | +6.6% | $7.92B | 40.5% | $2.44B | 12.5% |
| 2022 | $18.34B | +4.3% | $7.18B | 39.1% | $2.52B | 13.8% |
| 2021 | $17.59B | +2.5% | $7.17B | 40.8% | $2.79B | 15.9% |
| 2020 | $17.16B | - | $6.77B | 39.4% | $2.72B | 15.8% |
Full GEHC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See GEHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GEHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GEHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGEHC — Frequently Asked Questions
Quick answers to the most common questions about buying GEHC stock.
Is GEHC's revenue growth accelerating or slowing?
GEHC maintains +7.4% revenue growth, in line with its 5-year CAGR of +3.7%. TTM revenue stands at $20.0B. Growth rate remains consistent with historical average.
What is GEHC's long-term revenue growth rate?
GE HealthCare Technologies Inc.'s 5-year revenue CAGR of +3.7% reflects the sustained expansion pattern. Current YoY growth of +7.4% is near this long-term average.
How is GEHC's revenue distributed by segment?
GEHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.